Oxford Biomedica signs new deal to make AstraZeneca COVID shot
July 01, 2022 at 16:58 PM EDT
Britain's Oxford Biomedica announced an agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022. It has already manufactured more than 100 million doses since 2020.
